| Product Code: ETC6166539 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Armenia Pharmacogenetic Testing Market Overview |
3.1 Armenia Country Macro Economic Indicators |
3.2 Armenia Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Armenia Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Armenia Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Armenia Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Armenia Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Armenia Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Armenia Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Armenia Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Armenia Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Armenia Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Armenia Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and its benefits |
4.2.2 Growing prevalence of chronic diseases in Armenia |
4.2.3 Government initiatives to promote precision medicine and genetic testing |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities in remote areas |
4.3.2 High cost associated with pharmacogenetic testing |
4.3.3 Lack of skilled professionals in the field of genetics and personalized medicine |
5 Armenia Pharmacogenetic Testing Market Trends |
6 Armenia Pharmacogenetic Testing Market, By Types |
6.1 Armenia Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Armenia Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Armenia Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Armenia Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Armenia Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Armenia Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Armenia Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Armenia Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Armenia Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Armenia Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Armenia Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Armenia Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Armenia Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Armenia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Armenia Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Armenia Pharmacogenetic Testing Market Export to Major Countries |
7.2 Armenia Pharmacogenetic Testing Market Imports from Major Countries |
8 Armenia Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare providers offering pharmacogenetic testing services |
8.2 Percentage of population with access to pharmacogenetic testing |
8.3 Adoption rate of personalized medicine practices in clinical settings |
8.4 Research and development investments in pharmacogenetic testing technologies |
8.5 Number of partnerships between healthcare institutions and genetic testing companies |
9 Armenia Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Armenia Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Armenia Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Armenia Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Armenia Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Armenia Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Armenia Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Armenia Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Armenia Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Armenia Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Armenia Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here